Scarica l'app Stockscreener
135.05
2.58%
-3.58
Pre-mercato:
134.94
-0.11
-0.08%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché A Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$138.63
Aprire:
$138
Volume 24 ore:
1.81M
Relative Volume:
0.95
Capitalizzazione di mercato:
$38.29B
Reddito:
$6.95B
Utile/perdita netta:
$1.30B
Rapporto P/E:
29.55
EPS:
4.5696
Flusso di cassa netto:
$1.15B
1 W Prestazione:
-3.29%
1M Prestazione:
-2.39%
6M Prestazione:
+13.04%
1 anno Prestazione:
-11.41%
Intervallo 1D:
$133.96
$138.37
Intervallo di 1 settimana:
$133.96
$141.19
Portata 52W:
$96.43
$160.27
Agilent Technologies Inc Stock (A) Company Profile
Nome
Agilent Technologies Inc
Settore
Industria
Telefono
(408) 345-8886
Indirizzo
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Confronta A con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
A
Agilent Technologies Inc
|
135.05 | 39.30B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
TMO
Thermo Fisher Scientific Inc
|
625.98 | 240.25B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
235.01 | 169.58B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
693.85 | 55.18B | 4.17B | 1.03B | 940.22M | 12.61 |
|
IQV
Iqvia Holdings Inc
|
235.31 | 40.71B | 15.90B | 1.28B | 2.21B | 7.2842 |
Agilent Technologies Inc Stock (A) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-20 | Iniziato | HSBC Securities | Buy |
| 2026-01-05 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-12-15 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-12-09 | Iniziato | Goldman | Buy |
| 2025-12-02 | Iniziato | Morgan Stanley | Overweight |
| 2025-10-08 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-10-08 | Aggiornamento | UBS | Neutral → Buy |
| 2025-02-10 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-07-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-06-27 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-04-05 | Aggiornamento | Stifel | Hold → Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-12-12 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-11-17 | Downgrade | UBS | Buy → Neutral |
| 2023-09-28 | Iniziato | Bernstein | Mkt Perform |
| 2023-07-31 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-05-24 | Reiterato | Barclays | Equal Weight |
| 2023-05-24 | Reiterato | BofA Securities | Buy |
| 2023-05-24 | Reiterato | Citigroup | Neutral |
| 2023-05-24 | Reiterato | Credit Suisse | Outperform |
| 2023-05-24 | Reiterato | Evercore ISI | Outperform |
| 2023-05-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-24 | Reiterato | Robert W. Baird | Outperform |
| 2023-05-24 | Reiterato | SVB Securities | Outperform |
| 2023-05-24 | Reiterato | Stifel | Hold |
| 2023-05-24 | Reiterato | TD Cowen | Outperform |
| 2023-05-24 | Reiterato | Wells Fargo | Overweight |
| 2023-05-11 | Iniziato | Barclays | Equal Weight |
| 2023-01-10 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-07-20 | Iniziato | UBS | Buy |
| 2022-07-08 | Downgrade | Citigroup | Buy → Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-02-23 | Reiterato | BofA Securities | Buy |
| 2022-02-23 | Reiterato | Citigroup | Buy |
| 2022-02-23 | Reiterato | Cowen | Outperform |
| 2022-02-23 | Reiterato | Evercore ISI | Outperform |
| 2022-02-23 | Reiterato | Stifel | Hold |
| 2022-02-23 | Reiterato | Wells Fargo | Overweight |
| 2021-11-23 | Reiterato | BofA Securities | Buy |
| 2021-11-23 | Reiterato | Cowen | Outperform |
| 2021-11-23 | Reiterato | Stifel | Hold |
| 2021-03-18 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-02-17 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-25 | Aggiornamento | UBS | Neutral → Buy |
| 2020-11-17 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-09-30 | Iniziato | Atlantic Equities | Neutral |
| 2020-08-19 | Reiterato | BofA Securities | Neutral |
| 2020-08-19 | Reiterato | Citigroup | Neutral |
| 2020-08-19 | Reiterato | Jefferies | Buy |
| 2020-08-19 | Reiterato | Robert W. Baird | Outperform |
| 2020-08-19 | Reiterato | SVB Leerink | Outperform |
| 2020-08-19 | Reiterato | Stifel | Hold |
| 2020-08-19 | Reiterato | Wells Fargo | Overweight |
| 2020-02-24 | Downgrade | Needham | Buy → Hold |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Neutral |
| 2019-11-26 | Reiterato | Needham | Buy |
| 2019-11-15 | Iniziato | Stifel | Hold |
| 2019-10-18 | Downgrade | UBS | Buy → Neutral |
| 2019-07-16 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-07-15 | Downgrade | Barclays | Overweight → Equal Weight |
Mostra tutto
Agilent Technologies Inc Borsa (A) Ultime notizie
Agilent Technologies, Inc. $A Shares Sold by Teacher Retirement System of Texas - MarketBeat
Earnings preview: What to expect from Agilent Technologies' report - MSN
Assessing Agilent Technologies (A) Valuation After New AI Slide Scanner Launch In Europe - Yahoo Finance
Will Agilent’s AI-Enabled Digital Pathology Push Reshape Agilent Technologies' (A) Diagnostics Narrative? - Yahoo Finance
Is It Time To Reconsider Agilent Technologies (A) After Recent Share Price Weakness - Yahoo Finance
Agilent launches high-capacity slide scanner for European pathology labs By Investing.com - Investing.com Nigeria
Agilent launches high-throughput digital pathology slide scanner in Europe - Medical Economics
Agilent Accelerates Digital Pathology with the Launch of the Agilent S540MD Slide Scanner System - 01net
Agilent Technologies Launches Slide Scanner System in Europe - 富途资讯
Agilent launches high-capacity slide scanner for European pathology labs - Investing.com
Omics Lab Services: Global Market Review 2021-2025 and - GlobeNewswire
Omics Lab Services: Global Market Review 2021-2025 and Forecast 2026-2031 Featuring Profiles of Agilent Technologies, Q2 Solutions, Flomics Biotech, QIAGEN, Thermo Fisher Scientific and More - Yahoo Finance
Rakuten Investment Management Inc. Purchases New Shares in Agilent Technologies, Inc. $A - MarketBeat
Cantillon Capital Management LLC Has $396.88 Million Position in Agilent Technologies, Inc. $A - MarketBeat
Anatomic Pathology Market Research: Global and Regional Insights, Competition, Forecast and Opportunities, 2025-2033 | Astute Analytica - GlobeNewswire Inc.
Agilent Technologies (NYSE:A) Stock Rating Upgraded by Hsbc Global Res - MarketBeat
Agilent Technologies (NYSE:A) sheds 4.2% this week, as yearly returns fall more in line with earnings growth - Yahoo Finance
Agilent Technologies (A) Valuation Check After Analyst Upgrades And Upcoming Fiscal Q1 Earnings - simplywall.st
Anatomic Pathology Market Innovations and Key Players: Agilent - openPR.com
Universal Beteiligungs und Servicegesellschaft mbH Sells 9,703 Shares of Agilent Technologies, Inc. $A - MarketBeat
Earnings Preview: What to Expect From Agilent Technologies' Report - Yahoo Finance
Forensic Technology Market Is Going to Boom | Agilent Technologies • QIAGEN • Bio-Rad Laboratories • LGC Limited - openPR.com
Allstate Corp Purchases Shares of 9,640 Agilent Technologies, Inc. $A - MarketBeat
Agilent and Danaher Eye Qiagen Acquisition as Shares Surge 19% - Intellectia AI
Agilent, Danaher could be potential buyers of Qiagenanalyst (QGEN:NYSE) - Seeking Alpha
Pacific Heights Asset Management LLC Buys 18,000 Shares of Agilent Technologies, Inc. $A - MarketBeat
This Brinker International Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
HSBC Begins Coverage on Agilent Technologies (NYSE:A) - MarketBeat
HSBC Initiates Coverage of Agilent Technologies (A) with Buy Recommendation - Nasdaq
Demystifying Agilent Technologies: Insights From 12 Analyst Reviews - Benzinga
Agilent Technologies (A) Initiated with "Buy" Rating by HSBC | A Stock News - GuruFocus
HSBC initiates coverage on Agilent stock with Buy rating, $180 target - Investing.com
Nucleotide Market Is Going to Boom | Agilent Technologies • Bio-Rad Laboratories • QIAGEN - openPR.com
Profit Recap: Is Agilent Technologies Inc showing insider buyingQuarterly Earnings Summary & AI Driven Stock Price Forecasts - baoquankhu1.vn
Agilent Technologies, Inc. (NYSE:A) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Agilent Technologies, Inc. (NYSE:A) S&P 500 Today Global Lab Support - Kalkine Media
Gas Chromatography Systems Market to Reach US$ US$7,203.59 - openPR.com
Agilent Technologies, Inc. $A Shares Sold by Massachusetts Financial Services Co. MA - MarketBeat
Agilent Technologies, Inc. $A Shares Acquired by Lmcg Investments LLC - MarketBeat
Can Agilent Technologies Inc deliver alphaJuly 2025 Drop Watch & Technical Buy Zone Confirmation - baoquankhu1.vn
Eastern Bank Sells 53,575 Shares of Agilent Technologies, Inc. $A - MarketBeat
Agilent Technologies (A) Valuation Check After Evercore ISI Upgrade And Growing Analyst Optimism - Sahm
Boosting Agilent Technologies' Yield from 0.7% to 9.3% Through Options Trading - Intellectia AI
Agilent Technologies, Inc. $A Holdings Cut by Robeco Schweiz AG - MarketBeat
Agilent Technologies, Inc. $A Shares Sold by Nordea Investment Management AB - MarketBeat
Ashton Thomas Securities LLC Takes Position in Agilent Technologies, Inc. $A - MarketBeat
Tech Rally: What insider trading reveals about Agilent Technologies Inc stockRate Cut & Fast Gain Stock Tips - Bộ Nội Vụ
Agilent's Wide Moat Remains Intact in Its Life Science, Diagnostic, and Other Applied Markets - Morningstar
Agilent Technologies, Inc. $A Shares Purchased by SG Americas Securities LLC - MarketBeat
Agilent Technologies (NYSE:A) Stock Performs Better Than Its Underlying Earnings Growth Over Last Five Years - 富途牛牛
First Horizon Corp Makes New Investment in Agilent Technologies, Inc. $A - MarketBeat
Agilent Technologies Inc Azioni (A) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):